These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

763 related articles for article (PubMed ID: 19449339)

  • 1. Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models.
    Freund C; Mummery CL
    J Cell Biochem; 2009 Jul; 107(4):592-9. PubMed ID: 19449339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery.
    Braam SR; Passier R; Mummery CL
    Trends Pharmacol Sci; 2009 Oct; 30(10):536-45. PubMed ID: 19762090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models.
    Dambrot C; Passier R; Atsma D; Mummery CL
    Biochem J; 2011 Feb; 434(1):25-35. PubMed ID: 21269276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human embryonic stem cells for cardiomyogenesis.
    Habib M; Caspi O; Gepstein L
    J Mol Cell Cardiol; 2008 Oct; 45(4):462-74. PubMed ID: 18775434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Review of basic studies about the cardiac stem cell and regenerative medicine].
    Tamura Y; Fukuda K
    Nihon Rinsho; 2008 May; 66(5):908-14. PubMed ID: 18464509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells.
    Narazaki G; Uosaki H; Teranishi M; Okita K; Kim B; Matsuoka S; Yamanaka S; Yamashita JK
    Circulation; 2008 Jul; 118(5):498-506. PubMed ID: 18625891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of human-induced pluripotent stem cells.
    Park IH; Lerou PH; Zhao R; Huo H; Daley GQ
    Nat Protoc; 2008; 3(7):1180-6. PubMed ID: 18600223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiomyocyte differentiation from embryonic and adult stem cells.
    Passier R; Mummery C
    Curr Opin Biotechnol; 2005 Oct; 16(5):498-502. PubMed ID: 16099156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiomyocyte differentiation of human induced pluripotent stem cells.
    Zwi L; Caspi O; Arbel G; Huber I; Gepstein A; Park IH; Gepstein L
    Circulation; 2009 Oct; 120(15):1513-23. PubMed ID: 19786631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiomyocytes derived from human embryonic stem cells - characteristics and utility for drug discovery.
    Steel D; Hyllner J; Sartipy P
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):133-40. PubMed ID: 19152222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells.
    Yokoo N; Baba S; Kaichi S; Niwa A; Mima T; Doi H; Yamanaka S; Nakahata T; Heike T
    Biochem Biophys Res Commun; 2009 Sep; 387(3):482-8. PubMed ID: 19615974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial reprogramming of human somatic cells to generate pluripotent stem cells: a possible alternative to the controversial use of human embryonic stem cells.
    Romano G
    Drug News Perspect; 2008 Oct; 21(8):440-5. PubMed ID: 19034350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Directed differentiation of pluripotent stem cells: from developmental biology to therapeutic applications.
    Irion S; Nostro MC; Kattman SJ; Keller GM
    Cold Spring Harb Symp Quant Biol; 2008; 73():101-10. PubMed ID: 19329573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impacts of recent advances in cardiovascular regenerative medicine on clinical therapies and drug discovery.
    Murata M; Tohyama S; Fukuda K
    Pharmacol Ther; 2010 May; 126(2):109-18. PubMed ID: 20156482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Direct generation of pluripotent stem cells from differentiated somatic cells].
    Li L; Guan W; Ma Y; Li H; Bai X; Gong X
    Sheng Wu Gong Cheng Xue Bao; 2008 Oct; 24(10):1695-701. PubMed ID: 19149179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of human embryonic stem cell technologies to drug discovery.
    Sartipy P; Björquist P; Strehl R; Hyllner J
    Drug Discov Today; 2007 Sep; 12(17-18):688-99. PubMed ID: 17826681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progenitor cell therapy for heart disease.
    Gonzales C; Pedrazzini T
    Exp Cell Res; 2009 Nov; 315(18):3077-85. PubMed ID: 19747911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of 'stemness' and stem cell differentiation by microRNAs.
    Sartipy P; Olsson B; Hyllner J; Synnergren J
    IDrugs; 2009 Aug; 12(8):492-6. PubMed ID: 19629883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor.
    Niebruegge S; Bauwens CL; Peerani R; Thavandiran N; Masse S; Sevaptisidis E; Nanthakumar K; Woodhouse K; Husain M; Kumacheva E; Zandstra PW
    Biotechnol Bioeng; 2009 Feb; 102(2):493-507. PubMed ID: 18767184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous cardiac stem cells.
    Barile L; Messina E; Giacomello A; Marbán E
    Prog Cardiovasc Dis; 2007; 50(1):31-48. PubMed ID: 17631436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.